TXNRD1 and neoplasm: Mice lacking the selenoprotein thioredoxin reductase 1 (TXNRD1) in liver manifested a dramatically higher incidence of tumor development than control mice expressing TXNRD1 when both mouse lines were treated with a liver carcinogen, DEN [30].